A first-line antiretroviral therapy-resistant HIV patient with rhinoentomophthoromycosis.

Clicks: 355
ID: 58010
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The Conidiobolus coronatus-related rhinoentomophthoromycosis in immunocompetent and immunocompromised (HIV negative) individuals has been treated successfully with antifungal drugs. However, C. coronatus infections in first-line antiretroviral therapy (ART)-resistant (HIV infected) individuals particularly with rhinoentomophthoromycosis have not been reported previously. Here, we describe a case of itraconazole non-responding rhinoentomophthoromycosis in an HIV-infected patient with first-line antiretroviral (ART) drug resistance which was successfully managed through systematic diagnostic and therapeutic approaches in dermatologic setting. A 32-year-old HIV-1-infected man presented with painless swelling, nasal redness and respiratory difficulty. The patient was receiving first-line ART and had a history of traumatic injury before the onset of nasopharyngeal manifestations. The patient's previous history included oral candidiasis and pulmonary tuberculosis.
Reference Key
dhurataindian Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dhurat, Rachita;Kothavade, Rajendra J;Kumar, Anand;
Journal indian journal of medical microbiology
Year Year not found
DOI
10.4103/ijmm.IJMM_16_330
URL
Keywords
hiv aids antiviral drugs conidiobolus coronatus rhinoentomophthoromycosis hiv aids antiviral drugs conidiobolus coronatus

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.